Real-time financial, economic, and global news with market-focused context and analysis.
Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.
A Reuters poll of 65 economists finds the Bank of England is expected to maintain Bank Rate at 3.75% for the remainder of this year and into at least mid-2027. While higher energy prices tied to the U.S.-Israeli war on Iran have raised upside risks, poll respondents do not see widespread evidence yet of inflationary second-round effects that would …
Ales Bialiatski, co-recipient of the 2022 Nobel Peace Prize and recently released from prison, says that recent U.S.-brokered exchanges freeing detainees have not changed Belarus’ underlying repressive system. While Washington’s re-engagement under President Trump has produced hundreds of releases, Bialiatski and rights groups say new arrests conti…
NeOnc Technologies Holdings announced positive topline results from its Phase 2a trial of NEO100 in patients with aggressive IDH1-mutant gliomas, exceeding key survival benchmarks. The company is poised to engage with the FDA for a potential registrational study, advancing its intranasal brain cancer therapy. Insider buying following the data relea…
Chevron's Project Kilby and expanded Venezuela footprint create a clear, near-term earnings and cash-flow kicker for CVX. With a market cap near $412B, P/E ~20, and free cash flow of roughly $27B, Chevron can absorb project buildout risk while returning capital to shareholders. This trade targets that re-rating over the next 45 trading days with a …
Telos Corporation announced an expanded contract with the National Archives and Records Administration to deploy its FedRAMP Class D (High)-authorized Xacta SaaS platform, integrating AI-powered risk management tools to enhance federal cybersecurity governance, risk, and compliance.
Quantum X Labs Inc. has appointed Professor Daniel Freedman, an expert with extensive experience in AI, quantum physics, and computational science from leading tech companies and academia, as Distinguished Quantum Scientist. Freedman will guide the company's scientific strategy focusing on integrating artificial intelligence with quantum technology…
Neuronetics, a leader in interventional mental health, announced the integration of its NeuroStar TMS therapy's TrakStar practice management platform with AdvancedMD's cloud-based EHR and revenue cycle management system. This first-of-its-kind integration aims to reduce administrative burdens for providers by unifying treatment data, scheduling, an…
GlobalFoundries has finalized a $375 million research and development agreement with the U.S. Department of Commerce to advance its Quantum Technology Solutions business. This funding aims to accelerate domestic quantum semiconductor manufacturing, helping transition quantum computing from research to commercial-scale production and securing the US…
Birchtech Corp. (NYSE American: BCHT) announced it has reached an agreement in principle to acquire substantially all assets of a privately-held specialty activated carbon company. This strategic acquisition aims to provide Birchtech with initial commercial-scale thermal reactivation capabilities through its patented Carbon Rejuvenation technology.…
Virtu Financial and Abu Dhabi Securities Exchange (ADX) have launched the POSIT block-trading indications network for ADX-listed equity securities. This facility allows institutional investors and ADX members to execute large, electronic block trades with minimal market impact, supported by Virtu’s global liquidity network and facilitated through l…
Dynagas LNG Partners LP announced its financial results for Q2 and H1 2026, reporting increased net income and steady fleet utilization of above 95%. The partnership highlights improved charter rates, reduced debt costs, and a healthy revenue backlog of $0.73 billion with an average contract term of 4.4 years. However, geopolitical tensions and evo…
Greenland Mines has entered a new strategic phase as a rare earths and critical minerals company after Nasdaq approved its transaction application, ensuring full compliance with listing requirements. The company recently closed the $2.05 billion high-case NPV Sarfartoq rare earth project acquisition, highlighting its focus on neodymium and praseody…
CRISPR Therapeutics, a leader in gene-editing based biopharmaceuticals, announced a scheduled presentation at the Morgan Stanley 24th Annual Global Healthcare Conference. The company recently marked a historic milestone with the approval of CASGEVY®, the world's first CRISPR-based therapy, and continues to advance a robust pipeline across multiple …
PDS Biotechnology Corporation announced a private equity financing of up to $22.55 million led by Nant Capital, with Dr. Patrick Soon-Shiong joining as a board member. The funding will support late-stage clinical development of PDS0301, an immunocytokine targeting solid tumors, especially difficult-to-treat metastatic colorectal cancer. The transac…
Surrozen, Inc. has submitted an Investigational New Drug (IND) application for SZN-8141, a bifunctional antibody designed to treat diabetic macular edema by combining Wnt pathway activation and VEGF inhibition. This dual mechanism aims to reduce vascular leakage and promote retinal vascular integrity. Preclinical studies showed superior efficacy of…
Quoin Pharmaceuticals Ltd. announced the FDA has granted Rare Pediatric Disease (RPD) Designation for its lead drug candidate QRX003 for treating Peeling Skin Syndrome (PSS), marking its second RPD designation following one for Netherton Syndrome. This designation could enable Quoin to receive a Priority Review Voucher (PRV) with estimated market v…
StablecoinX Inc., the Nasdaq-listed company focused on the Ethena digital dollar ecosystem, announced the appointment of Christopher Jensen as CEO and board director. Jensen, with extensive institutional investment and digital asset experience from Franklin Templeton, succeeds Ted Chen who remains chairman. Jensen will lead day-to-day operations ac…
Draganfly Inc. has been selected as a qualified supplier across all five capability streams of Canada's Defence Drone Initiative Marketplace, enabling the company to engage in contract opportunities with Canadian Armed Forces and Coast Guard. This selection aligns Draganfly with Canada's $180 billion defense procurement investment over the next dec…
ZenaTech plans to leverage its recent acquisition of Florida-based Green Earth Powerwashing LLC to develop a franchise-based Drone as a Service (DaaS) power washing business. The company aims to integrate AI drone technology to improve safety, speed, and service consistency, initially targeting Florida's dense high-rise and commercial property mark…
NeoVolta Inc., a U.S.-based energy technology company specializing in scalable energy storage solutions, announced its financial results release for Q4 and fiscal year ended June 30, 2026. The earnings will be disclosed after market close on September 23, 2026, followed by a conference call to discuss operational progress, strategic priorities, and…
Liberty Defense Holdings Ltd. announced the debut of the HEXWAVE I-Configuration at the GSX 2026 event in Atlanta. This new single-panel millimeter wave detection system enables full-body threat scanning in constrained entry points by having individuals rotate once in front of the sensor, enhancing security screening in areas where multi-panel setu…
Tempest Therapeutics, a clinical-stage biotech company developing advanced in vivo CAR-T therapies for cancer and autoimmune diseases, announced that CEO Matt Angel will present at the H.C. Wainwright 28th Annual Global Investment Conference. The presentation will cover the company's progress and pipeline, notably their lead candidate TPST-4003. Th…
Lifeward Ltd., a biomedical innovation company traded on Nasdaq under ticker LFWD, has released an updated investor presentation highlighting its strategy to scale its neurorehabilitation platform, leverage reimbursement infrastructure, and expand its distribution network. The company also emphasizes its diversified biomedical pipeline, including a…
Optimi Health Corp., a commercial-stage pharmaceutical manufacturer specializing in regulated psychedelic drug products, announced its participation in the H.C. Wainwright 28th Annual Global Investment Conference where management will present and be available for meetings. The company produces GMP-grade MDMA and psilocybin products, supplying to cl…
Vericel Corporation, a leader in advanced therapies for sports medicine and severe burn care, announced it will present at the 24th Annual Morgan Stanley Global Healthcare Conference. The presentation will highlight the company's innovative cell therapies and specialty biologics, including MACI, Epicel, and NexoBrid, marketed in the United States.
